PGGM Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-56,592
Closed -$11.6M 400
2017
Q3
$11.6M Sell
56,592
-81,067
-59% -$18.9M 0.06% 288
2017
Q2
$33.5M Sell
137,659
-1,355
-1% -$318K 0.17% 162
2017
Q1
$33.2M Buy
+139,014
New +$32.4M 0.17% 174
2015
Q4
Sell
-214,271
Closed -$58.2M 391
2015
Q3
$58.2M Sell
214,271
-3,469
-2% -$1.07M 0.32% 76
2015
Q2
$66.1M Sell
217,740
-13,891
-6% -$4.14M 0.34% 72
2015
Q1
$68.9M Buy
231,631
+59,400
+34% +$16.9M 0.33% 73
2014
Q4
$44.3M Sell
172,231
-4,452
-3% -$1.11M 0.2% 116
2014
Q3
$42.6M Buy
+176,683
New +$39.5M 0.2% 108

Other funds holding AGN

PGGM Investments's AGN Position: Q4 2017 in Review

PGGM Investments sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 56,592 shares — an estimated $11.6M sold.

PGGM Investments first reported a position in AGN in Q3 2014 and held it in 8 quarters. The position peaked at $68.9M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • PGGM Investments reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • PGGM Investments sold 56,592 Allergan plc shares in Q4 2017, an estimated $11.6M.
  • PGGM Investments first reported a position in Allergan plc in Q3 2014 and held it in 8 quarters.
  • PGGM Investments's Allergan plc position peaked at $68.9M in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on PGGM Investments's 13F filing for Q4 2017, filed 29 Jan 2018.